Increasing evidence shows that FBXO proteins are involved in tumor development as either pro- or anti-oncogenic factors; for example, FBXO4 inhibits breast cancer development by interacting with intercellular adhesion molecule-1 (ICAM-1), promoting its ubiquitination, and decreasing its stability [31]. This evidence concerns the gene ICAM1 and breast carcinoma.